TP53 and glioblastoma: In the current study, alterations in the p53 pathway, BCL-2 protein family, inhibitor of apoptosis protein, and several growth factor pathways involved in the regulation of programmed cell apoptosis have been identified, further providing possible targets for new therapies based on these apoptotic pathways in GBM.